The DOI matches its Crossref record; 183 of the 185 references it cites were found in a registry or an index.
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2.
Open accessAbstract
The insulin receptor substrate proteins IRS1 and IRS2 are key targets of the insulin receptor tyrosine kinase and are required for hormonal control of metabolism. Tissues from insulin-resistant and diabetic humans exhibit defects in IRS-dependent signalling, implicating their dysregulation in the initiation and progression of metabolic disease. However, IRS1 and IRS2 are regulated through a complex mechanism involving phosphorylation of >50 serine/threonine residues (S/T) within their long, unstructured tail regions. In cultured cells, insulin-stimulated kinases (including atypical PKC, AKT, SIK2, mTOR, S6K1, ERK1/2 and ROCK1) mediate feedback (autologous) S/T phosphorylation of IRS, with both positive and negative effects on insulin sensitivity. Additionally, insulin-independent (heterologous) kinases can phosphorylate IRS1/2 under basal conditions (AMPK, GSK3) or in response to sympathetic activation and lipid/inflammatory mediators, which are present at elevated levels in metabolic disease (GRK2, novel and conventional PKCs, JNK, IKKβ, mPLK). An emerging view is that the positive/negative regulation of IRS by autologous pathways is subverted/co-opted in disease by increased basal and other temporally inappropriate S/T phosphorylation. Compensatory hyperinsulinaemia may contribute strongly to this dysregulation. Here, we examine the links between altered patterns of IRS S/T phosphorylation and the emergence of insulin resistance and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance in adipocytes is associated with impaired phosphorylation of insulin receptor substrate 1 (IRS-1) in obesity, which is further impaired in T2DM”
From Effect of Exercise Training on Fat Loss—Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution (2021) · cites this paper as Copps and White, 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Insulin Stimulates PKCζ-mediated Phosphorylation of Insulin Receptor Substrate-1 (IRS-1)
Liu, Y., Paz, K., Herschkovitz, A., Alt, A., Tennenbaum, T., Sampson, S. R., Ohba, M., Kuroki, T., LeRoith, D., & Zick, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007281200 · Cited by 159
RetractedHerschkovitz, A., Liu, Y., Ilan, E., Ronen, D., Boura‐Halfon, S., & Zick, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610949200 · Cited by 98
RetractedG Protein–Coupled Receptor Kinase 2 Plays a Relevant Role in Insulin Resistance and Obesity
García‐Guerra, L., Nieto-Vázquez, I., Vila‐Bedmar, R., Jurado-Pueyo, M., Zalba, G., Dı́ez, J., Murga, C., Fernández‐Veledo, S., Mayor, F., & Lorenzo, M. (2010) · Diabetes · doi:10.2337/db10-0771 · Cited by 92
RetractedPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 2×
“In contrast, ‘priming’ phosphorylation of AKT at S473—by mammalian target of rapamycin (mTOR) complex 2 (mTORC2) [21] (Fig.”
BackgroundEndoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844 · cited 1×
“phosphorylation is frequently used as evidence of insulin resistance (or its resolution) in mice, despite the influence of insulin on S307 phosphorylation and the probable contribution of other phospho-S/Ts [44].”
BackgroundNewgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165 · cited 1×
“Increased plasma BCAA levels in obese, insulin-resistant persons have long been regarded as part of an insulin-resistant metabolic ‘signature’ [110, 111], but supplementation of rodent diets with mixed BCAA or leucine has not clarified that this is diabetogenic [111, 112].”
BackgroundSkeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · cited 2×
“Prospective studies first identify insulin resistance in human skeletal muscle, which is thought to contribute, via a dys-metabolic process, to the emergence of phenotypic disease [3, 74].”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,860 · cited 2×
“but not Akt1, gene deletion in mice causes a diabetes-like phenotype [22].”
BackgroundAbsence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677 · cited 3×
“1b); S6K2 can also phosphorylate IRS1 in vitro, but does not compensate for loss of S6K1 in knockout mice [51, 106].”
BackgroundAdipose tissue as an endocrine organ
Galić, S., Oakhill, J. S., & Steinberg, G. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.018 · Cited by 1,654 · cited 1×
“IKKβ and JNK—Impaired glucose uptake and/or insulin resistance within adipose tissue can contribute to the development of type 2 diabetes [164], likely by altering its secretion of adipokines, such as adiponectin or retinol-binding protein 4 (reviewed in [165]).”
BackgroundYu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 2×
“NEFA levels causes insulin resistance in rats, accompanied by elevated muscle IRS1 S307 (hS312) phosphorylation [146].”
BackgroundSelf-citationAguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487 · cited 2×
“Treatment of CHO cells with the low-specificity JNK agonist anisomycin was used to identify S307 (hS312) near the IRS1 PTB domain as a major site of phosphorylation [38].”
BackgroundMethodSelf-citationDirect Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate
Franke, T. F., Kaplan, D. R., Cantley, L. C., & Toker, A. (1997) · Science · doi:10.1126/science.275.5300.665 · Cited by 1,462 · cited 1×
“Recruitment of dimeric PI3K (p85•p110) to IRS produces membrane phosphatidylinositol 3,4,5-trisphosphate (PIP3), which recruits the S/T kinase AKT [19].”
BackgroundItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390 · cited 2×
“Lipid infusion in humans can also activate muscle PKCδ and (canonical) PKCβ2 [154].”
BackgroundMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
The nuts and bolts of AGC protein kinases
Pearce, L. R., Komander, D., & Alessi, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2822 · Cited by 1,294 · cited 2×
“The activation/levels of two other IRS kinases, ROCK1 and G protein-coupled receptor kinase 2 (GRK2), is mechanistically independent of IRS [20] but is clearly influenced by insulin and altered in type 2 diabetes [88–90].”
BackgroundGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267 · cited 2×
“Intramyocellular diacylglycerol can be generated in humans and rodents by normal phospholipid metabolism or, experimentally, by the infusion of TAG emulsions plus heparin to activate tissue lipase [153].”
BackgroundMethodSelf-citationInsulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191 · cited 1×
“Additionally, the expanded adipose compartment in diabetes/obesity produces proinflammatory cytokines such as TNFα and IL1β that can contribute to insulin resistance systemically (reviewed in [79]).”
BackgroundLipid-induced insulin resistance: unravelling the mechanism
Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60408-4 · Cited by 1,189 · cited 4×
“intramyocellular TAG , hepatosteatosis) (reviewed in [74]).”
BackgroundInfluentialCusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139 · cited 4×
“In contrast with AKT, basal or insulin-stimulated ERK1/2 activation in diabetic muscle is unchanged or increased in several studies, compatible with its partial independence from IR/IRS [82, 86].”
BackgroundResultInfluentialThe TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Толкачева, Т. А., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123 · cited 1×
“It can now be appreciated that feedback S/T phosphorylation of IRS by mTORC1 and/or S6K1 underlies their disappearance during persistent insulin stimulation [49, 50].”
BackgroundHsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B., et al. (2011) · Science · doi:10.1126/science.1199498 · Cited by 1,084 · cited 2×
“Related pathways that contribute to the regulation of AKT include: (1) mTORC1 phosphor-ylation/ stabilisation of GRB10 [174], which inhibits productive interaction of IRS with a key phosphotyrosine in IR [175]; (2) inhibition of mTORC2 by S6K1-mediated phosphorylation of rictor [176]; and (3) transcriptional upregulat…”
BackgroundAguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010 · cited 2×
“In cultured cells that produce very little IRS2, insulin stimulates S307 phosphorylation via a PI3K pathway requiring the IRS1 YXXM motifs [39, 40].”
BackgroundSelf-citationSelective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 959
Morino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811 · cited 3×
“Given their co-incidence and propensity to aggravate one another, it cannot be stated whether hyperinsulinaemia or dyslipidaemia (or still other factors) underlie increased IRS S/T phosphorylation in the pre-diabetic period [85].”
BackgroundInfluentialBlüher, M., Michael, M. D., Peroni, O. D., Ueki, K., Carter, N., Kahn, B. B., & Kahn, C. R. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00199-5 · Cited by 806 · cited 1×
“in all tissues, exhibit abnormal or severely compromised adipocyte differentiation [16, 17].”
BackgroundShah, O. J., Wang, Z., & Hunter, T. R. (2004) · Current Biology · doi:10.1016/j.cub.2004.08.026 · Cited by 800 · cited 1×
“It can now be appreciated that feedback S/T phosphorylation of IRS by mTORC1 and/or S6K1 underlies their disappearance during persistent insulin stimulation [49, 50].”
BackgroundSerine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex
Gao, Z., Hwang, D. H., Bataille, F., Lefevre, M., York, D. A., Quon, M. J., & Ye, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209459200 · Cited by 777 · cited 1×
“In contrast, in mammalian cells, IKKβ physically associates with IRS1, and its TNFα-stimulated activity correlates with phosphorylation of mS307/hS312—consistent with IKKβ phosphorylation of this residue in vitro [167].”
BackgroundThe role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G. W., Befroy, D., Zemany, L., Kahn, B. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705408104 · Cited by 759
Zisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743 · cited 1×
“IKKβ and JNK—Impaired glucose uptake and/or insulin resistance within adipose tissue can contribute to the development of type 2 diabetes [164], likely by altering its secretion of adipokines, such as adiponectin or retinol-binding protein 4 (reviewed in [165]).”
BackgroundLi, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733 · cited 1×
“Thus, though AKT signalling to mTORC1 is diminished in diabetes, the over-supply of nutrients in obesity is hypothesised to promote mTORC1/S6K phosphorylation of IRS and other targets, aggravating insulin resistance (reviewed in [109, 110]).”
BackgroundInsulin signaling in health and disease
White, M. F. (2003) · Science · doi:10.1126/science.1092952 · Cited by 733 · cited 17×
“IRS2 (but not IRS1) protein concentration in mouse liver is decreased during refeeding via a PI3K-dependent mechanism [68].”
BackgroundInfluentialFROM MICE TO MEN: Insights into the Insulin Resistance Syndromes
Biddinger, S. B., & Kahn, C. R. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.124723 · Cited by 714 · cited 1×
“It also underlies risk factors—including hyperglycaemia, dyslipidaemia and hypertension—for the clustering of type 2 diabetes with cardiovascular disease, non-alcoholic fatty liver disease and related maladies (metabolic syndrome) [2].”
BackgroundNutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1
Um, S. H., D'Alessio, D., & Thomas, G. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.003 · Cited by 690 · cited 2×
“Increased plasma BCAA levels in obese, insulin-resistant persons have long been regarded as part of an insulin-resistant metabolic ‘signature’ [110, 111], but supplementation of rodent diets with mixed BCAA or leucine has not clarified that this is diabetogenic [111, 112].”
BackgroundPlomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J. R., & Pedersen, B. K. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2939 · Cited by 627 · cited 4×
“TNFα activates multiple kinases in muscle, including S6K, ERK1/2, IKKβ and the IRS1 mS307/hS312 kinase JNK1; however, muscle hS312 phosphorylation is not significantly elevated by TNFα infusion prior to the period in which TNFα causes reduced IRS1 tyrosine phosphorylation and insulin resistance [34].”
BackgroundInfluentialRui, L., Aguirre, V., Kim, J. K., Shulman, G. I., Lee, A., Corbould, A. M., Dunaif, A. E., & White, M. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10934 · Cited by 611 · cited 3×
“Other agents—including insulin in rodent and human tissues—can stimulate phosphorylation of S307 via JNK-independent pathways [39].”
BackgroundSelf-citationPhosphorylation of IRS proteins, insulin action, and insulin resistance
Boura-Halfon, S., & Zick, Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90437.2008 · Cited by 598 · cited 6×
“Thus, S/T phosphorylation at many sites together converts IRS proteins to an inactive state, separable from their inactivation by degradation; it was further suggested that this ‘array phosphorylation’ of IRS (particularly within the PTB-proximal regions) is necessary for the desensitisation of insulin signalling by d…”
BackgroundInfluentialRole that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis
McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., & Alessi, D. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600633 · Cited by 594 · cited 1×
“Comparison of knock-in mice with constitutively active GSK3 isoforms (α, β, or α and β) demonstrates the predominance of GSK3β in muscle, yet none of these mice show impaired AKT activation or become diabetic [140].”
BackgroundKhamzina, L., Veilleux, A., Bergeron, S., & Marette, A. (2005) · Endocrinology · doi:10.1210/en.2004-0921 · Cited by 562 · cited 1×
“Rodents fed a high-fat diet to cause obesity and insulin resistance show increased basal mTORC1→S6K activation in metabolic tissues, with pronounced phosphorylation of IRS1 at S632 and/or S302 (hS636, hS307) [106, 115].”
BackgroundEpinephrine-induced insulin resistance in man
Deibert, D. C., & Defronzo, R. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109718 · Cited by 557 · cited 1×
“The correlation between excessive β-adrenergic activity and insulin resistance has long been noted [131].”
BackgroundA Molecular Basis for Insulin Resistance
Paz, K., Hemi, R., LeRoith, D., Karasik, A., Elhanany, E., Kanety, H., & Zick, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29911 · Cited by 556
Kubota, N., Tobe, K., Terauchi, Y., Eto, K., Yamauchi, T., Suzuki, R., Tsubamoto, Y., Komeda, K., Nakano, R., Miki, H., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1880 · Cited by 519
Reaven, G. M. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.002 · Cited by 517 · cited 1×
“Insulin resistance, defined as reduced responsiveness of tissues to normal insulin concentrations, is a principal feature of type 2 diabetes, which leads to compensatory hyperinsulinaemia [1].”
BackgroundPKC-θ knockout mice are protected from fat-induced insulin resistance
Kim, J. K., Fillmore, J. J., Sunshine, M. J., Albrecht, B., Higashimori, T., Kim, D.-W., Liu, Z.-X., Soos, T. J., Cline, G. W., O’Brien, W. R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422230 · Cited by 500 · cited 2×
“5 mmol/l NEFA) impairs muscle IRS1 tyrosine phosphorylation, PI3K activity and glucose disposal, and these effects are lost in Prkcq (PKCθ) knockout mice [147].”
BackgroundSamuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497 · cited 1×
“Rodent and human studies validate the contribution of dyslipidaemia to skeletal muscle and liver insulin resistance via diacylglycerol-mediated activation of nPKCs, including PKCθ [65, 146, 147], PKCδ [148] and PKCε [149, 150] (reviewed in [74, 94]).”
BackgroundBidirectional modulation of insulin action by amino acids.
Patti, M., Brambilla, E., Luzi, L., Landaker, E. J., & Kahn, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1326 · Cited by 493 · cited 1×
“Nonetheless, mTORC1/S6K can be stimulated by nutrients independently of IRS [107]—most clearly by branched-chain amino acids (BCAA) such as leucine [108].”
BackgroundElevated plasma endothelin in patients with diabetes mellitus
Takahashi, K., Ghatei, M. A., Lam, H. ‐., O’Halloran, D., & Bloom, S. R. (1990) · Diabetologia · doi:10.1007/bf00403325 · Cited by 489 · cited 1×
“Increased plasma concentration of the vasoconstrictive ET-1 polypeptide is associated with insulin resistance and/or hypertension [128, 129], which is, in turn, promoted by direct and indirect (sympathoadrenal and angiotensin II-dependent) effects of compensatory hyperinsulinaemia to cause sodium retention (reviewed i…”
BackgroundBiddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
Pleiotropic Insulin Signals are Engaged by Multisite Phosphorylation of IRS-1
Sun, X., Crimmins, D. L., Myers, M. G., Miralpeix, M., & White, M. F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7418 · Cited by 465
Self-citationTremblay, F., Brûlé, S., Hee Um, S., Li, Y., Masuda, K., Roden, M., Sun, X. J., Krebs, M., Polakiewicz, R. D., Thomas, G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706517104 · Cited by 465 · cited 26×
“Mice lacking mTOR or raptor in muscle, or S6K1 in all tissues, highlight the role of mTORC1→S6K signalling in the growth and maintenance of skeletal muscle (reviewed in [107]).”
BackgroundInfluentialDong, X. C., Copps, K. D., Guo, S., Li, Y., Kollipara, R., DePinho, R. A., & White, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.006 · Cited by 463 · cited 2×
“Insulin stimulation of the RAS→mitogen-activated protein kinase (MAPK) cascade depends partly on other substrates of the IR, such as SHC, yet activation of the MAPKs extracellular signal-regulated kinase-1 and -2 (ERK1/2) is impaired in IRSdeficient mouse liver [11].”
BackgroundSelf-citationInsulin signaling meets mitochondria in metabolism
Cheng, Z., Tseng, Y. D., & White, M. F. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.06.005 · Cited by 460 · cited 1×
“The binding of insulin to the insulin receptor (IR), and in muscle tissues to hybrid insulin/ IGF1 receptors (IR/IGF1R) [7], promotes the autophosphorylation of a trio of regulatory loop tyrosine residues, disinhibiting IR tyrosine kinase activity toward IRS [8].”
BackgroundSelf-citationc-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade
Lee, Y. H., Giraud, J., Davis, R. J., & White, M. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208359200 · Cited by 441 · cited 1×
“mTOR complex 1 (mTORC1) can mediate insulin- or anisomycin-stimulated S307 phosphor-ylation [41], casting some doubt on the significance of insulin-stimulated JNK phosphorylation of S307 observed in cultured cells [42].”
BackgroundSelf-citationCharacterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1
Dibble, C. C., Asara, J. M., & Manning, B. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00735-09 · Cited by 433 · cited 1×
“Related pathways that contribute to the regulation of AKT include: (1) mTORC1 phosphorylation/ stabilisation of GRB10 [174], which inhibits productive interaction of IRS with a key phosphotyrosine in IR [175]; (2) inhibition of mTORC2 by S6K1-mediated phosphorylation of rictor [176]; and (3) transcriptional upregulati…”
BackgroundTanti, J.-F., & Jager, J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.07.004 · Cited by 430 · cited 4×
“However, as reviewed herein and elsewhere [5, 6], unique phospho-S/T on IRS1 can have negative (or positive) effects on insulin signalling that are currently unexplainable in either structural terms or by a requirement for multiple phosphorylation.”
BackgroundInfluentialInsulin modulates gluconeogenesis by inhibition of the coactivator TORC2
Dentin, R., Liu, Y., Koo, S., Hedrick, S. A., Vargas, T., Heredia, J., Yates, J. R., & Montminy, M. (2007) · Nature · doi:10.1038/nature06128 · Cited by 407 · cited 3×
“However, SIK2 kinase activity is positively regulated by insulin via phosphorylation by AKT2 [144], suggesting an autologous feedback role in the regulation of IRS.”
BackgroundTzatsos, A., & Kandror, K. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.63-76.2006 · Cited by 399 · cited 3×
“Surprisingly—given the apparent involvement of phospho-S632 (hS636) in desensitisation of insulin signalling [53, 91]—double mutation of S632/ 635 to alanine in CHO cells reduces IRS1 tyrosine phosphorylation and PI3K binding [71].”
BackgroundTremblay, F., Krebs, M., Dombrowski, L., Brehm, A., Bernroider, E., Roth, E., Nowotny, P., Waldhäusl, W., Marette, A., & Roden, M. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2674 · Cited by 370 · cited 1×
“In contrast, infusion of complex amino acid mixtures (AA) into humans with clamped hyperinsulinaemia (to repress gluconeogenesis from amino acid precursors) decreases the rate of glucose disposal by about a third, with post-clamp muscle biopsies showing decreased IRS1 tyrosine phosphorylation and increased phosphoryla…”
BackgroundFunctional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369 · cited 1×
“The binding of insulin to the insulin receptor (IR), and in muscle tissues to hybrid insulin/ IGF1 receptors (IR/IGF1R) [7], promotes the autophosphorylation of a trio of regulatory loop tyrosine residues, disinhibiting IR tyrosine kinase activity toward IRS [8].”
BackgroundProtein Kinase C θ Inhibits Insulin Signaling by Phosphorylating IRS1 at Ser1101
Li, Y., Soos, T. J., Li, X., Wu, J., DeGennaro, M., Sun, X., Littman, D. R., Birnbaum, M. J., & Polakiewicz, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400186200 · Cited by 363 · cited 3×
“Of these, phospho-S312, -S616, -S636 and -S1101 are associated with desensitisation of insulin signalling (above and [56, 65]), whereas phospho-S1223 has a sensitising effect [31].”
BackgroundGreenberg, A. S., Shen, W., Muliro, K. V., Patel, S., Souza, S. C., Roth, R. A., & Kraemer, F. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104436200 · Cited by 363 · cited 1×
“Potentially contributing to the latter finding, ERK1/2 can promote lipolysis and NEFA-mediated insulin resistance, both by downregulating adipocyte perilipin [120] and activating hormone-sensitive lipase [121].”
BackgroundJNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
Solinas, G., & Karin, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-151340 · Cited by 347 · cited 23×
“Solinas G, Karin M. JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction.”
BackgroundInfluentialmTOR couples cellular nutrient sensing to organismal metabolic homeostasis
Howell, J. J., & Manning, B. D. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.12.003 · Cited by 334 · cited 2×
“Nonetheless, mTORC1/S6K can be stimulated by nutrients independently of IRS [107]—most clearly by branched-chain amino acids (BCAA) such as leucine [108].”
BackgroundRothman, D. L., Magnusson, I., Cline, G., Gerard, D., Kahn, C. R., Shulman, R. G., & Shulman, G. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.983 · Cited by 325 · cited 1×
“Related studies show that decreased muscle glucose transport via the GLUT4 path underlies this alteration [74, 77].”
BackgroundStructure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor
Eck, M. J., Dhe‐Paganon, S., Trüb, T., Nolte, R. T., & Shoelson, S. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81236-2 · Cited by 321 · cited 1×
“The PH domain is the principal module that links IRS1 with the activated IR [26], whereas the PTB domain enhances this interaction via binding to the phospho-NPEY motif within the IR juxtamembrane region [27].”
BackgroundBouzakri, K., Roques, M., Gual, P., Espinosa, S., Guebre-Egziabher, F., Riou, J.-P., Laville, M., Le Marchand-Brustel, Y., Tanti, J.-F., & Vidal, H. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1319 · Cited by 305
Zhang, J., Gao, Z., Yin, J., Quon, M. J., & Ye, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806480200 · Cited by 304 · cited 3×
“Notably, in mouse embryonic fibroblasts, IKKβ is required for TNFα-stimulated phosphorylation of IRS1 S265; mutation of this residue in HEK293 cells (hS270) reduces TNFα stimulation of IRS1–S6K interaction and other IRS1 phospho-S/T elevated in adipose tissue from ob/ob mice [55].”
BackgroundPlasma immunoreactive endothelin in essential hypertension
Kohno, M., Yasunari, K., Murakawa, K., Yokokawa, K., Horio, T., Fukui, T., & Takeda, T. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90527-k · Cited by 291 · cited 1×
“Increased plasma concentration of the vasoconstrictive ET-1 polypeptide is associated with insulin resistance and/or hypertension [128, 129], which is, in turn, promoted by direct and indirect (sympathoadrenal and angiotensin II-dependent) effects of compensatory hyperinsulinaemia to cause sodium retention (reviewed i…”
BackgroundÖst, A., Svensson, K., Ruishalme, I., Brännmark, C., Franck, N., Krook, H., Sandström, P., Kjølhede, P., & Strålfors, P. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00023 · Cited by 274 · cited 2×
“upstream insulin resistance), the implication is that mTORC1 activity is reduced in insulinresistant human adipocytes in vivo [116].”
BackgroundMacotela, Y., Emanuelli, B., Bång, A. M., Espinoza, D., Boucher, J., Beebe, K. D., Gall, W., & Kahn, C. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021187 · Cited by 271 · cited 1×
“Increased plasma BCAA levels in obese, insulin-resistant persons have long been regarded as part of an insulin-resistant metabolic ‘signature’ [110, 111], but supplementation of rodent diets with mixed BCAA or leucine has not clarified that this is diabetogenic [111, 112].”
BackgroundGao, Z., Zuberi, A. R., Quon, M. J., Dong, Z., & Ye, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300423200 · Cited by 262 · cited 1×
“AKT may also phosphorylate S267 (hS272) in TNFα-treated cells [105].”
BackgroundInsulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302
Werner, E. D., Lee, J., Hansen, L., Yuan, M., & Shoelson, S. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405203200 · Cited by 257
Takano, A., Usui, I., Haruta, T., Kawahara, J., Uno, T., Iwata, M., & Kobayashi, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5050-5062.2001 · Cited by 257 · cited 2×
“Prior treatment with proteasome inhibitors can block the insulin-induced degradation of IRS1, but not its intracellular transit or the desensitisation of downstream signalling and glucose uptake [48].”
BackgroundMothe‐Satney, I., & OBBERGHEN, E. V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11222 · Cited by 254 · cited 1×
“For example, the simultaneous mutation to alanine of four S/Ts near IRS1 YXXMs (mS612/632/662/731A; hS616/636/ 666/736A) was shown to increase basal and insulinstimulated IRS1 tyrosine phosphorylation and associated PI3K activity [33].”
BackgroundAlterations of insulin signaling in type 2 diabetes: A review of the current evidence from humans
Fröjdö, S., Vidal, H., & Pirola, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.019 · Cited by 247 · cited 6×
“Any regulatory effects of AKT-mediated IRS phosphorylation are obscured in knockout mice by the necessity of AKT2 for downstream signalling [22]; however, less complete impairment of AKT activity, such as that observed in diabetic muscle, might have a partial homeostatic effect, by reducing inhibitory feedback via dow…”
BackgroundResultInfluentialFea, K. D., & Roth, R. A. (1997) · Biochemistry · doi:10.1021/bi971157f · Cited by 242 · cited 1×
“Mutation of S612 is sufficient to protect HEK293 cells against the desensitisation of insulin signalling by phorbol 12-myristate 13-acetate (PMA)-activated novel and conventional PKC (cPKC) isoforms [155].”
BackgroundJakobsen, S. N., Hardie, D. G., Morrice, N., & Tornqvist, H. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100483200 · Cited by 238 · cited 1×
“Interestingly, treatment of C2C12 muscle cells with the AMPK agonist 5-aminoimidazole-4carboxamide-1-β-D-ribofuranoside (AICAR) has an additive effect, with insulin, to promote IRS1-associated PI3K activity [145].”
BackgroundThe Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man
Krebs, M., Brunmair, B., Brehm, A., Artwohl, M., Szendroedi, J., Nowotny, P., Roth, E., Fürnsinn, C., Promintzer, M., Anderwald, C., et al. (2007) · Diabetes · doi:10.2337/db06-1016 · Cited by 230 · cited 1×
“Similar human studies demonstrate the involvement of mTORC1 in these effects [114], as well as the stimulation by AA of IRS1 S1101 (mS1097) phosphorylation in muscle, likely by S6K1 [56].”
BackgroundXu, X., Sarikas, A., Dias-Santagata, D. C., Dolios, G., Lafontant, P. J., Tsai, S.-C., Zhu, W., Nakajima, H., Nakajima, H. O., Field, L. J., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.009 · Cited by 225 · cited 1×
“522–574 of (mouse) IRS1 are required for its ubiquitination and degradation via the cullin 7 E3 ligase [66].”
BackgroundRavichandran, L. V., Esposito, D. L., Chen, J. Y. ‐., & Quon, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007231200 · Cited by 217 · cited 1×
“In contrast, in Fao or NIH3T3 cells stably expressing IR, overexpression of PKCζ enhances the dissociation from IR and decrease in IRS1 tyrosine phosphorylation caused by prolonged insulin stimulation [95, 96].”
BackgroundEssential Role of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 in Adipocyte Differentiation
Miki, H., Yamauchi, T., Suzuki, R., Komeda, K., Tsuchida, A., Kubota, N., Terauchi, Y., Kamon, J., Kaburagi, Y., Matsui, J., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.7.2521-2532.2001 · Cited by 213 · cited 1×
“in all tissues, exhibit abnormal or severely compromised adipocyte differentiation [16, 17].”
BackgroundBandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2351 · Cited by 210 · cited 2×
“Increased basal phosphorylation of a few IRS S/T—S312 [87], S323 [60], and S636 [91] (mS307, mS318, mS632)—has been described in muscle of type 2 diabetic individuals, whereas basal and stimulated phosphorylation of S330 (mS325) is specifically decreased in muscle of obese insulin-resistant individuals [60].”
BackgroundAndreozzi, F., Laratta, E., Sciacqua, A., Perticone, F., & Sesti, G. (2004) · Circulation Research · doi:10.1161/01.res.0000126501.34994.96 · Cited by 208 · cited 1×
“Conversely, increased ERK1/2 phosphorylation of mS612/hS616 is associated with angiotensin II-mediated impairment of endothelial nitric oxide synthase activation (by AKT) in vascular endothelial cells [124].”
BackgroundTargets for TNF-α-induced lipolysis in human adipocytes
Rydén, M., Nordström, E. A., Blomqvist, L., Perbeck, L. G., Dicker, A., & Arner, P. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.010 · Cited by 207 · cited 1×
“Potentially contributing to the latter finding, ERK1/2 can promote lipolysis and NEFA-mediated insulin resistance, both by downregulating adipocyte perilipin [120] and activating hormone-sensitive lipase [121].”
BackgroundGreene, M. W., Sakaue, H., Wang, L., Alessi, D. R., & Roth, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209153200 · Cited by 203 · cited 1×
“Counter to this idea, the mutation of mS307 to alanine in cultured cells has a rapamycin-like effect, in that it blocks IRS1 disappearance during prolonged insulin stimulation [51, 52]; however, it is not shown that S307A mutation alone alters IRS1 localisation and/or PI3K signalling in these studies.”
BackgroundIrs1 Serine 307 Promotes Insulin Sensitivity in Mice
Copps, K. D., Hançer, N. J., Opare-Ado, L., Qiu, W., Walsh, C., & White, M. F. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.003 · Cited by 197 · cited 1×
“In contrast, we used genetic knock-in to replace wild-type IRS1 in mice with a mutant form (S307A, ‘A’) lacking the ability to be phosphorylated at S307 (hS312) [171].”
MethodSelf-citationRabøl, R., Petersen, K. F., Dufour, S., Flannery, C. A., & Shulman, G. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110105108 · Cited by 195 · cited 1×
“Frequent sampling of postprandial blood in these individuals—in combination with more sophisticated tracer/ imaging techniques to monitor metabolism—reveals the redirection of dietary carbohydrate away from glycogen synthesis in muscle and toward the insulin-driven synthesis of TAG in the liver [75, 76].”
BackgroundPaz, K., Liu, Y., Shorer, H., Hemi, R., LeRoith, D., Quan, M., Kanety, H., Seger, R., & Zick, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28816 · Cited by 194 · cited 1×
“AKT—In contrast to PKCλ, overexpression of membrane-localised AKT (in CHO-T cells) promotes retention of IRS1 tyrosine phosphorylation during prolonged insulin stimulation (after 1 h), with no effect on its acute phosphor-ylation (after 2 min) [104].”
BackgroundFarese, R. V., Sajan, M. P., & Standaert, M. L. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523000901 · Cited by 187 · cited 2×
“signalling is pleiotropic, combined defects in AKT- and aPKC-promoted muscle glucose uptake might be key in the initiation of metabolic disease [23].”
BackgroundWhelan, S. A., Dias, W. B., Thiruneelakantapillai, L., Lane, M. D., & Hart, G. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077818 · Cited by 185 · cited 1×
“910–1037) or elsewhere can also impair IRS1–PI3K interaction [63, 64].”
BackgroundShah, O. J., & Hunter, T. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01254-05 · Cited by 183 · cited 8×
“Yet S302 phosphorylation is implicated in the degradation of IRS1 caused by excessive mTORC1→S6K1 activation [51].”
BackgroundInfluentialLong, Y. C., Cheng, Z., Copps, K. D., & White, M. F. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00983-10 · Cited by 183 · cited 2×
“IRS-deficient muscles also undergo atrophy, with impaired phosphorylation of S6K and its substrate, ribosomal S6 protein [14].”
BackgroundSelf-citationThe Pleckstrin Homology Domain Is the Principle Link between the Insulin Receptor and IRS-1
Yenush, L., Makati, K. J., Smith-Hall, J., Ishibashi, O., Myers, M. G., & White, M. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24300 · Cited by 177 · cited 1×
“The PH domain is the principal module that links IRS1 with the activated IR [26], whereas the PTB domain enhances this interaction via binding to the phospho-NPEY motif within the IR juxtamembrane region [27].”
BackgroundSelf-citationTemporal Dynamics of Tyrosine Phosphorylation in Insulin Signaling
Schmelzle, K., Kane, S., Gridley, S., Lienhard, G. E., & White, F. M. (2006) · Diabetes · doi:10.2337/db06-0148 · Cited by 177 · cited 1×
“Although IR phosphorylates numerous other proteins [9], work with knockout mice has revealed that many insulin responses, including the regulation of carbohydrate and lipid metabolism, require IRS1 and IRS2 [10].”
BackgroundLuo, J., Field, S. J., Lee, J. Y., Engelman, J. A., & Cantley, L. C. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503088 · Cited by 174 · cited 1×
“localisation in insulin-treated cells [57]; however, it remains unclear to what degree the active fraction is S/T phosphorylated.”
BackgroundG Alpha-q/11 Protein Plays a Key Role in Insulin-Induced Glucose Transport in 3T3-L1 Adipocytes
Imamura, T., Vollenweider, P., Egawa, K., Clodi, M., Ishibashi, K., Nakashima, N., Ugi, S., Adams, J. W., Brown, J. H., & Olefsky, J. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6765 · Cited by 174
Farese, R. V., Sajan, M. P., Yang, H., Li, P., Mastorides, S., Gower, W. R., Nimal, S., Choi, C. S., Kim, S., Shulman, G. I., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31408 · Cited by 173
Laustsen, P. G., Russell, S. J., Cui, L., Entingh-Pearsall, A., Holzenberger, M., Liao, R., & Kahn, C. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01110-06 · Cited by 173
Liberman, Z., & Eldar-Finkelman, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410610200 · Cited by 172 · cited 1×
“) Serine residues phosphorylated by GSK3 are typically primed by phosphorylation at a nearby site (SXXXS motif), and mutation of both S332 and S336 of IRS1 (hS337, hS341) to alanine enhances both basal and insulin-stimulated tyrosine phosphorylation of IRS1, as well as insulin-stimulated AKT activation in cultured cel…”
BackgroundRole of Rho-kinase in regulation of insulin action and glucose homeostasis
Furukawa, N., Ongusaha, P. P., Jahng, W. J., Araki, K., Choi, C. S., Kim, H.-J., Lee, Y. H., Kaibuchi, K., Kahn, B. B., Masuzaki, H., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.011 · Cited by 172 · cited 14×
“Some data suggest that ROCK1 inhibits, rather than promotes, IRS signalling [125], and it has not been demonstrated whether phosphomimetic mutation of mS632 and mS635 can overcome the negative effects of ROCK1 inhibition/knockdown.”
BackgroundInfluentialcJun NH2-terminal kinase 1 (JNK1): Roles in metabolic regulation of insulin resistance
Sabio, G., & Davis, R. J. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.004 · Cited by 170 · cited 2×
“By analogy with JNK1 activity, IRS1 S307 phosphorylation could also have mixed, tissue-specific effects that are obscured by the standard knock-in approach [166].”
BackgroundDynamics of Insulin Signaling in 3T3-L1 Adipocytes
Inoue, G., Cheatham, B., Emkey, R., & Kahn, C. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11548 · Cited by 166
The Phosphotyrosine Interactome of the Insulin Receptor Family and Its Substrates IRS-1 and IRS-2
Hanke, S., & Mann, M. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800407-mcp200 · Cited by 165 · cited 1×
“The tyrosines on IRS1 demonstrated by mutation or MS to recruit dimeric PI3K, GRB2 or SHP2 signalling proteins are indicated by the red bars [18, 178].”
BackgroundBeeson, M., Sajan, M. P., Dizon, M. N., Grebenev, D., Gomez-Daspet, J., Miura, A., Kanoh, Y., Powe, J. L., Bandyopadhyay, G. K., Standaert, M. L., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1926 · Cited by 163 · cited 2×
“Additionally, AKT S473 phosphorylationmay not fully reflect upstream IRS→PI3K signalling, as non-diabetic but glucose-intolerant individuals can show significantly impaired muscle aPKC activation [83].”
BackgroundHorike, N., Takemori, H., Katoh, Y., Doi, J., Min, L., Asano, T., Sun, X. J., Yamamoto, H., Kasayama, S., Muraoka, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211770200 · Cited by 161 · cited 1×
“S789 of IRS1 when co-expressed in cells [143].”
BackgroundBegum, N., Sandu, O. A., Ito, M., Lohmann, S. M., & Smolenski, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110508200 · Cited by 159 · cited 1×
“Some data suggest that ROCK1 inhibits, rather than promotes, IRS signalling [125], and it has not been demonstrated whether phosphomimetic mutation of mS632 and mS635 can overcome the negative effects of ROCK1 inhibition/knockdown.”
BackgroundInsulin signaling and glucose transport in insulin resistant human skeletal muscle
Karlsson, H. K. R., & Zierath, J. R. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0030-9 · Cited by 159 · cited 2×
“Direct observations of human muscle do not support diminished IRS protein concentration as a primary cause of insulin resistance, though most studies have not examined IRS2 ([80, 81], and reviewed in [4]).”
BackgroundKnockout of PKCα Enhances Insulin Signaling Through PI3K
Letiges, M., Plomann, M., Standaert, M. L., Bandyopadhyay, G. K., Sajan, M. P., Kanoh, Y., & Farese, R. V. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0809 · Cited by 158
Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation
Carlson, C. J., White, M. F., & Rondinone, C. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.082 · Cited by 157 · cited 1×
“mTOR complex 1 (mTORC1) can mediate insulin- or anisomycin-stimulated S307 phosphor-ylation [41], casting some doubt on the significance of insulin-stimulated JNK phosphorylation of S307 observed in cultured cells [42].”
BackgroundSelf-citationPKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
Bézy, O., Tran, T. T., Pihlajamäki, J., Suzuki, R., Emanuelli, B., Winnay, J., Mori, M. A., Haas, J. T., Biddinger, S. B., Leitges, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46045 · Cited by 152 · cited 4×
“sensitivity and signalling, improves glucose tolerance, and reduces age-dependent hepatosteatosis [148].”
BackgroundInfluentialWeigert, C., Hennige, A. M., Lehmann, R., Brodbeck, K., Baumgärtner, F., Schaüble, M., Häring, H. U., & Schleicher, E. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509782200 · Cited by 142 · cited 2×
“PKCδ phosphorylation of S318/ hS323 and other residues may co-opt this chronic function to desensitise insulin signalling [99, 100, 103].”
BackgroundConsidine, R. V., Nyce, M. R., Allen, L. E., Morales, L. M., Triester, S., Serrano, J., Colberg, J., Lanza-Jacoby, S., & Caro, J. F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118001 · Cited by 141 · cited 1×
“skeletal muscle and liver tissues are characterised by increased PKCθ and PKCε levels, respectively [151, 152].”
BackgroundTzatsos, A., & Tsichlis, P. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610101200 · Cited by 140 · cited 1×
“impairment of insulin-stimulated AKT activation caused by glucose deprivation [141].”
BackgroundLiu, Y., Paz, K., Herschkovitz, A., Alt, A., Tennenbaum, T., Sampson, S. R., Ohba, M., Kuroki, T., LeRoith, D., & Zick, Y. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.w118.003466 · Cited by 139
Yatabe, M., Yatabe, J., Yoneda, M., Watanabe, T., Otsuki, M., Felder, R. A., José, P. A., & Sanada, H. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29028 · Cited by 131 · cited 1×
“Increased plasma concentration of the vasoconstrictive ET-1 polypeptide is associated with insulin resistance and/or hypertension [128, 129], which is, in turn, promoted by direct and indirect (sympathoadrenal and angiotensin II-dependent) effects of compensatory hyperinsulinaemia to cause sodium retention (reviewed i…”
BackgroundMoeschel, K., Beck, A., Weigert, C., Lammers, R., Kalbacher, H., Voelter, W., Schleicher, E. D., Häring, H., & Lehmann, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402477200 · Cited by 130 · cited 2×
“Though S318A mutation aids retention of IRS1 tyrosine phosphor-ylation during prolonged stimulation, it impairs acute AKT S473 phosphorylation in skeletal muscle cells [101].”
BackgroundLiu, Y., Herschkovitz, A., Boura‐Halfon, S., Ronen, D., Paz, K., LeRoith, D., & Zick, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9668-9681.2004 · Cited by 127 · cited 1×
“Similarly, mutation of S408 or S357 (hS413, hS362) at least partially blocks the desensitisation of insulin signalling by PKC pathways in PMA-treated cells [157, 158].”
BackgroundTargeted Disruption of ROCK1 Causes Insulin Resistance in Vivo
Lee, D. H., Shi, J., Jeoung, N. H., Kim, M., Zabolotny, J. M., Lee, S. W., White, M. F., Wei, L., & Kim, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c900014200 · Cited by 125 · cited 2×
“There may also be a priming effect of S632 (hS636) phosphorylation by rho-associated coiled-coil containing protein kinase 1 (ROCK1) in mice [71, 72].”
BackgroundSelf-citationMorino, K., Neschen, S., Bilz, S., Sono, S., Tsirigotis, D., Reznick, R. M., Moore, I., Nagai, Y., Samuel, V., Sebastian, D., et al. (2008) · Diabetes · doi:10.2337/db06-0454 · Cited by 125 · cited 1×
“Shulman and colleagues created transgenic mice with moderate overexpression in skeletal muscle (~twofold vs littermates) of nonmutant IRS1, or mutant IRS1 with alanine substitution of three serine residues—S302/307/612A (hS307/312/ 616A)—to block phosphorylation [170].”
BackgroundSelf-citationTurban, S., & Hajduch, É. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.12.022 · Cited by 124 · cited 2×
“) Activation of aPKCs by ceramide can contribute to insulin resistance in mice, though this appears to be due mostly to effects on AKT (reviewed in [94]).”
BackgroundMdm2 is involved in the ubiquitination and degradation of G‐protein‐coupled receptor kinase 2
Salcedo, A., Mayor, F., & Penela, P. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601351 · Cited by 119 · cited 20×
“ET-1 treatment of these cells reduces GLUT4 translocation, both by GRK2 kinase-independent effects on Gαq/11 (or IR), and by decreasing the level and tyrosine phosphorylation of IRS1 [126].”
BackgroundInfluentialWick, K. R., Werner, E. D., Langlais, P. R., Ramos, F. J., Dong, L., Shoelson, S. E., & Liu, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208518200 · Cited by 119 · cited 1×
“Related pathways that contribute to the regulation of AKT include: (1) mTORC1 phosphorylation/ stabilisation of GRB10 [174], which inhibits productive interaction of IRS with a key phosphotyrosine in IR [175]; (2) inhibition of mTORC2 by S6K1-mediated phosphorylation of rictor [176]; and (3) transcriptional upregulati…”
BackgroundPratipanawatr, W., Pratipanawatr, T., Cusi, K., Berria, R., Adams, J. M., Jenkinson, C. P., Maezono, K., DeFronzo, R. A., & Mandarino, L. J. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2572 · Cited by 118
Samuelsson, A., Bollano, E., Mobini, R., Larsson, B.-M., Ömerovic, E., Fu, M. L. X., Waagstein, F., & Holmäng, A. B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00974.2005 · Cited by 118 · cited 1×
“In this light, it is notable that increased expression of type 1 angiotensin II receptors, promoted by experimental hyperinsulinaemia, correlates with increased IRS1 phosphor-ylation on mS369 [134].”
BackgroundAustin, R. L., Rune, A., Bouzakri, K., Zierath, J. R., & Krook, A. (2008) · Diabetes · doi:10.2337/db07-0763 · Cited by 109 · cited 3×
“In another early study, TNFα—an inflammatory cytokine that can cause insulin resistance in healthy human muscle [34, 35]—was shown to stimulate multi-site S/T phosphorylation of IRS1 and IRS2, blocking their interaction with an IR juxtamembrane domain peptide [36].”
BackgroundQiao, L.-Y., Zhande, R., Jetton, T. L., Zhou, G., & Sun, X. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201494200 · Cited by 104
Increased protein kinase C theta in skeletal muscle of diabetic patients
Itani, S. I., Pories, W. J., MacDonald, K. G., & Dohm, G. L. (2001) · Metabolism · doi:10.1053/meta.2001.22512 · Cited by 101 · cited 1×
“Diabetic skeletal muscle and liver tissues are characterised by increased PKCθ and PKCε levels, respectively [151, 152].”
BackgroundGiraud, J., Leshan, R. L., Lee, Y.-H., & White, M. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308631200 · Cited by 100 · cited 2×
“However, mS302 (hS307) phosphorylation in cultured cells potentiates, rather than inhibits, downstream insulin signalling by IRS1 [73].”
BackgroundSelf-citationStructural and biochemical characterization of the KRLB region in insulin receptor substrate-2
Wu, J., Tseng, Y. D., Xu, C., Neubert, T. A., White, M. F., & Hubbard, S. R. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1388 · Cited by 98 · cited 3×
“Abbreviations a.a. Amino acid residue AA Complex amino acid mixtures AMPK AMP-activated protein kinase aPKC Atypical protein kinase C cPKC Conventional protein kinase C ERK Extracellular signal-regulated kinase ET-1 Endothelin 1 GPCR G-protein coupled receptor GRB2 Growth factor receptor-bound protein 2 GRK2 G protein…”
BackgroundSelf-citationCipolletta, E., Campanile, A., Santulli, G., Sanzari, E., Leosco, D., Campiglia, P., Trimarco, B., & Iaccarino, G. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp252 · Cited by 95 · cited 4×
“While tissue GRK2 levels have been correlated with plasma norepinephrine/epinephrine levels [132], GRK2 can be upregulated in cultured cells by chronic insulin [89, 90], potentially as a result of PI3K-dependent stabilisation of GRK2 [133].”
BackgroundInfluentialHennige, A. M., Stefan, N., Kapp, K., Lehmann, R., Weigert, C., Beck, A., Moeschel, K., Mushack, J., Schleicher, E. D., & Häring, H. (2006) · The FASEB Journal · doi:10.1096/fj.05-4635fje · Cited by 94
Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cdelta
Greene, M. W., MORRICE, N. A., Garofalo, R. S., & Roth, R. A. (2004) · Biochemical Journal · doi:10.1042/bj20031493 · Cited by 91 · cited 2×
“However, S302, S318 and S570 (hS307, hS323, hS574) are the major sites, and mutation of these residues alleviates inhibition of IRS1 tyrosine phosphorylation by IR in vitro [156].”
BackgroundUsui, I., Imamura, T., Satoh, H., Huang, J., Babendure, J. L., Hupfeld, C. J., & Olefsky, J. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600297 · Cited by 90 · cited 1×
“GRK2 can additionally interfere directly with Gαq/11mediated signalling via its RGS (regulator of G protein signalling) domain/GAP activity [127].”
BackgroundDanielsson, A., Öst, A., Nyström, F. H., & Strålfors, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500230200 · Cited by 89 · cited 1×
“Interestingly, insulin-stimulated phosphorylation of S307 (mS302) in human primary adipocytes correlates with donor insulin sensitivity [116] and is decreased in adipocytes of humans with type 2 diabetes [117].”
BackgroundGreene, M. W., & Garofalo, R. S. (2002) · Biochemistry · doi:10.1021/bi015992f · Cited by 88 · cited 2×
“(However, dephosphorylation of basally present phospho-S/Ts is itself inhibitory vs no dephosphorylation [138].”
BackgroundInsulin signaling regulating genes: effect on T2DM and cardiovascular risk
Prudente, S., Morini, E., & Trischitta, V. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.215 · Cited by 87 · cited 1×
“Interestingly, this region of IRS1 contains the human Gly972Arg polymorphism that in some studies is associated with type 2 diabetes risk [61] and might reduce Y941 or Y989 phosphorylation by disrupting an (unknown) IRS1 secondary structure [62].”
BackgroundBard-Chapeau, E. A., Hevener, A. L., Long, S., Zhang, E. E., Olefsky, J. M., & Feng, G. (2005) · Nature Medicine · doi:10.1038/nm1227 · Cited by 87 · cited 2×
“phospho-S612 (hS616) is clearly decreased [122].”
BackgroundKarlsson, H., Ahlsén, M., Zierath, J. R., Wallberg‐Henriksson, H., & Koistinen, H. A. (2006) · Diabetes · doi:10.2337/db05-0853 · Cited by 86 · cited 1×
“aPKC signalling (and/or other steps in the muscle GLUT4 path) might be more sensitive to dysregulation than AKT, as one study found no difference vs control individuals in phosphorylation of AKT (S473) or AKTsubstrate of 160 kDa (AS160), despite the presence of impaired glucose disposal [84].”
BackgroundKlein, A., Berkaw, M. N., Buse, M. G., & Ball, L. E. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900207-mcp200 · Cited by 86 · cited 1×
“910–1037) or elsewhere can also impair IRS1–PI3K interaction [63, 64].”
BackgroundClark, S. F., Molero, J.-C., & James, D. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3819 · Cited by 83 · cited 1×
“For example, in 3T3L1 adipocytes, prolonged insulin stimulation causes transit of hyper-S/T-phosphorylated IRS1 from low-density membrane (LDM/high speed pellet) to the cytosol, and this can be inhibited by the mTORC1 inhibitor rapamycin [47, 48].”
BackgroundStorgaard, H., Song, X. M., Jensen, C. B., Madsbad, S., Björnholm, M., Vaag, A. A., & Zierath, J. R. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2770 · Cited by 82
Usui, I., Imamura, T., Babendure, J. L., Satoh, H., Lu, J.-C., Hupfeld, C. J., & Olefsky, J. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0429 · Cited by 82
Kim, J., Yeh, D. C., Ver, M. R., Li, Y., Carranza, A., Conrads, T. P., Veenstra, T. D., Harrington, M. A., & Quon, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501439200 · Cited by 79
McGettrick, A., Feener, E. P., & Kahn, C. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412300200 · Cited by 78 · cited 1×
“Interestingly, this region of IRS1 contains the human Gly972Arg polymorphism that in some studies is associated with type 2 diabetes risk [61] and might reduce Y941 or Y989 phosphorylation by disrupting an (unknown) IRS1 secondary structure [62].”
BackgroundMetabolic functions of atypical protein kinase C: “good” and “bad” as defined by nutritional status
Farese, R. V., & Sajan, M. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00608.2009 · Cited by 77 · cited 1×
“(In human muscle, the PKCι orthologue of PKCλ appears to predominate [93].”
BackgroundGlobal IRS-1 phosphorylation analysis in insulin resistance
Langlais, P. R., Yi, Z., Finlayson, J., Luo, M., Mapes, R., Filippis, E. D., Meyer, C., Plummer, E., Tongchinsub, P., Mattern, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2271-9 · Cited by 76 · cited 11×
“PKCδ phosphorylation of S318/ hS323 and other residues may co-opt this chronic function to desensitise insulin signalling [99, 100, 103].”
BackgroundInfluentialTzatsos, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027748 · Cited by 74
IKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance
Hung (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000065 · Cited by 73 · cited 4×
“Lee DF, Kuo HP, Chen CT, et al. IKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance.”
BackgroundInfluentialWeigert, C., Kron, M., Kalbacher, H., Pohl, A. K., Runge, H., Häring, H., Schleicher, E. D., & Lehmann, R. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0102 · Cited by 68 · cited 3×
“Conversely, phosphomimetic mutation of S318 to glutamate (S318E) enhances early signalling [70].”
BackgroundTanak, H., & Yavuz, M. (2010) · Journal of Molecular Modeling · doi:10.1007/s00894-009-0539-5 · Cited by 66
Rincon, S. V. D., Guo, Q., Morelli, C., Shiu, H. Y., Surmacz, E., & Miller, W. H. (2004) · Oncogene · doi:10.1038/sj.onc.1208104 · Cited by 66 · cited 1×
“PKCδ phosphorylation of S318/ hS323 and other residues may co-opt this chronic function to desensitise insulin signalling [99, 100, 103].”
BackgroundYi, Z., Langlais, P. R., Filippis, E. A. D., Luo, M., Flynn, C. R., Schroeder, S., Weintraub, S. T., Mapes, R., & Mandarino, L. J. (2007) · Diabetes · doi:10.2337/db06-1355 · Cited by 65 · cited 2×
“[59]), we emphasise that this regulatory function might be subverted/co-opted by diabetogenic factors—not excluding Copps and White Page 8”
BackgroundMethodExperimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer
Lü (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000291 · Cited by 65
Nakamori, Y., Emoto, M., Fukuda, N., Taguchi, A., Okuya, S., Tajiri, M., Miyagishi, M., Taira, K., Wada, Y., & Tanizawa, Y. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601065 · Cited by 65 · cited 1×
“In 3T3L1 cells, TNFα-stimulated phosphorylation of mS307 is dependent upon the interaction of IRS1 with the NEMO/IKKγ subunit of the IĸB kinase complex, promoted by the actindirected motor protein MYO1C [168].”
BackgroundLuo, M., Langlais, P. R., Yi, Z., Lefort, N., Filippis, E. A. D., Hwang, H., Christ-Roberts, C. Y., & Mandarino, L. J. (2007) · Endocrinology · doi:10.1210/en.2007-0049 · Cited by 63 · cited 20×
“Regardless, defective muscle IRS1→PI3K→AKT signalling in lean normoglycaemic offspring of type 2 diabetics has been correlated with increased basal S/T phosphorylation of IRS1—including at mTORC1 sites S312 and S636 (mS307, mS632), and S616 (mS612) [85].”
BackgroundInfluentialLuo, M., Reyna, S. M., Wang, L., Yi, Z.-P., Carroll, C. A., Dong, L., Langlais, P. R., Weintraub, S. T., & Mandarino, L. J. (2005) · Endocrinology · doi:10.1210/en.2005-0260 · Cited by 59 · cited 3×
“Of these, phospho-S312, -S616, -S636 and -S1101 are associated with desensitisation of insulin signalling (above and [56, 65]), whereas phospho-S1223 has a sensitising effect [31].”
BackgroundNawaratne, R., Gray, A., Jørgensen, C. H., Downes, C. P., Siddle, K., & Sethi, J. K. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0536 · Cited by 58 · cited 4×
“S24, altering its membrane-binding properties in cultured cells [29] (Fig.”
InfluentialIn vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes
Chun, K., Choi, K., Lee, D.-H., Jung, Y., Henry, R. R., Ciaraldi, T. P., & Kim, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00538.2010 · Cited by 53 · cited 2×
“Insulin-stimulated ROCK1 activity is also decreased in muscle of obese diabetic humans, in conjunction with upregulation of its kinase inhibitor RhoE [88].”
BackgroundAltered Glucose Homeostasis in Mice with Liver-specific Deletion of Src Homology Phosphatase 2
Matsuo, K., Delibegović, M., Matsuo, I., Nagata, N., Liu, S., Bettaieb, A., Xi, Y., Araki, K., Yang, W., Kahn, B. B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.153734 · Cited by 53 · cited 2×
“IRS1 phospho-S307 (hS312) increases, contrary to the inhibitory function of S307 phosphorylation in cultured cells [25].”
BackgroundAnis, Y., Leshem, O., Reuveni, H., Wexler, I. D., Sasson, R. B., Yahalom, B., Laster, M., Raz, I., Sasson, S. B., Shafrir, E., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1444-1 · Cited by 52 · cited 1×
“Importantly, and consistent with these data, GRK2-interfering peptides improve insulin sensitivity in diabetic animal models [137]; thus, GRK2 is a potential target for the treatment of insulin resistance.”
BackgroundMüssig, K., Fiedler, H., Staiger, H., Weigert, C., Lehmann, R., Schleicher, E. D., & Häring, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.154 · Cited by 50 · cited 1×
“Treatment of C2C12 cells with inhibitors implicates JNK and mTORC1 as additional insulin-stimulated S318 kinases [102], demonstrating that multiple pathways may”
BackgroundWeigert, C., Hennige, A. M., Brischmann, T., Beck, A., Moeschel, K., Schaüble, M., Brodbeck, K., Häring, H.-U., Schleicher, E. D., & Lehmann, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506134200 · Cited by 50 · cited 1×
“Though S318A mutation aids retention of IRS1 tyrosine phosphor-ylation during prolonged stimulation, it impairs acute AKT S473 phosphorylation in skeletal muscle cells [101].”
BackgroundHuang, W., Bansode, R. R., Bal, N. C., Mehta, M., & Mehta, K. D. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m019687 · Cited by 47 · cited 1×
“Knockout of the gene encoding PKCβ protects mice against high-fat diet induced obesity, insulin resistance, and hepatosteatosis, but might do so independently of effects on IRS [163].”
BackgroundTHE MOLECULAR BASIS OF INSULIN ACTION
G.Myers, J. A. M. F. W. M. (2002) · CRC Press eBooks · doi:10.1201/b12794-13 · Cited by 47
Das, F., Ghosh‐Choudhury, N., Dey, N., Mandal, C. C., Mahimainathan, L., Kasinath, B. S., Abboud, H. E., & Choudhury, G. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.246397 · Cited by 44 · cited 2×
“Related pathways that contribute to the regulation of AKT include: (1) mTORC1 phosphor-ylation/ stabilisation of GRB10 [174], which inhibits productive interaction of IRS with a key phosphotyrosine in IR [175]; (2) inhibition of mTORC2 by S6K1-mediated phosphorylation of rictor [176]; and (3) transcriptional upregulat…”
BackgroundOriente, F., Andreozzi, F., Romano, C., Perruolo, G., Perfetti, A., Fiory, F., Miele, C., Bèguinot, F., & Formisano, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508570200 · Cited by 43 · cited 1×
“In contrast, prolonged insulin stimulation in cultured cells can increase PKCα binding to IRS1 in complex with 14-3-3ε [161].”
BackgroundWaraich, R. S., Weigert, C., Kalbacher, H., Hennige, A. M., Lutz, S. Z., Häring, H., Schleicher, E. D., Voelter, W., & Lehmann, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708588200 · Cited by 43 · cited 1×
“Similarly, mutation of S408 or S357 (hS413, hS362) at least partially blocks the desensitisation of insulin signalling by PKC pathways in PMA-treated cells [157, 158].”
BackgroundCho, M., Rao, M. N., Koch, W. J., THOMAS, S. A., Palmiter, R. D., & Rockman, H. A. (1999) · Circulation · doi:10.1161/01.cir.99.20.2702 · Cited by 42 · cited 1×
“While tissue GRK2 levels have been correlated with plasma norepinephrine/epinephrine levels [132], GRK2 can be upregulated in cultured cells by chronic insulin [89, 90], potentially as a result of PI3Kdependent stabilisation of GRK2 [133].”
BackgroundFritsche, L., Neukamm, S. S., Lehmann, R., Kremmer, E., Hennige, A. M., Hunder-Gugel, A., Schenk, M., Häring, H., Schleicher, E. D., & Weigert, C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2010 · Cited by 40 · cited 1×
“As far less is currently known about IRS2 S/T phosphorylation, we refer the reader to other, limited sources [5, 92].”
BackgroundShort-Term Overeating Induces Insulin Resistance in Fat Cells in Lean Human Subjects
Danielsson, A., Fagerholm, S., Öst, A., Franck, N., Kjølhede, P., Nyström, F. H., & Strålfors, P. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00037 · Cited by 39 · cited 1×
“ERK1/2 activation is also sensitised to insulin in adipocytes from humans fed a highenergy diet, potentially contributing to the adaptive expansion of adipose tissue [119].”
BackgroundPhosphorylation of Irs1 at SER-522 Inhibits Insulin Signaling
Giraud, J., Haas, M., Feener, E. P., Copps, K. D., Dong, X. C., Dunn, S. L., & White, M. F. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0159 · Cited by 38 · cited 1×
“We have shown that insulin-stimulated S522 phosphorylation—which is inhibited by small interfering RNA against AKT—impairs IRS1 tyrosine phosphorylation and PI3K binding in HEK293 cells [58].”
BackgroundSelf-citationKnockout of PKC Enhances Insulin Signaling Through PI3K
Letiges, M. (2002) · Molecular Endocrinology · doi:10.1210/me.16.4.847 · Cited by 37
Mack, E., Ziv, E., Reuveni, H., Kalman, R., Niv, M. Y., Jörns, A., Lenzen, S., & Shafrir, E. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.881 · Cited by 36 · cited 1×
“Rodent and human studies validate the contribution of dyslipidaemia to skeletal muscle and liver insulin resistance via diacylglycerol-mediated activation of nPKCs, including PKCθ [65, 146, 147], PKCδ [148] and PKCε [149, 150] (reviewed in [74, 94]).”
BackgroundGRK2 Negatively Regulates Glycogen Synthesis in Mouse Liver FL83B Cells
Shahid, G., & Hussain, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700744200 · Cited by 34 · cited 1×
“In FL83B mouse liver cells, glycogen synthesis is upregulated by GRK2 knockdown, and this is associated with decreased basal and insulinstimulated IRS1 S307 (hS312) phosphorylation [136].”
BackgroundLiberman, Z., Plotkin, B., Tennenbaum, T., & Eldar-Finkelman, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00050.2008 · Cited by 31 · cited 1×
“PKCβ2 can phosphorylate IRS1 on mS336/hS341 in vitro, suggesting it is a priming kinase for GSK3 phosphorylation of IRS1 [162].”
BackgroundSommerfeld, M. R., Metzger, S. U., Stosik, M., Tennagels, N., & Eckel, J. (2004) · Biochemistry · doi:10.1021/bi049640v · Cited by 30 · cited 1×
“However, PKCζ can phosphorylate IRS1 in vitro on S498, S570 and S612 (hS503, hS574, hS616), with phospho-S570 having an adverse effect on PI3K binding [98].”
BackgroundKatsnelson, A. (2011) · Nature Medicine · doi:10.1038/nm1211-1536 · Cited by 20
Protein kinase Cα regulates insulin receptor signaling in skeletal muscle
Cipok, M., Aga‐Mizrachi, S., Bak, A., Feurstein, T., Steinhart, R., Brodie, C., & Sampson, S. R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.008 · Cited by 18 · cited 1×
“PKCα in rodent muscle associates basally with IRS1; insulin transiently disrupts this interaction while increasing PKCα association with AKT [160].”
BackgroundDownregulation of Grb2 contributes to the insulin-sensitizing effect of calorie restriction
Liu, X., Liu, M., Zhang, J., Bai, X. S., Ramos, F. J., Remmen, H. V., Richardson, A. G., Liu, F., Dong, L., & Liu, F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90714.2008 · Cited by 18 · cited 1×
“conjunction with increased AKT activation [123].”
Boura‐Halfon, S., Shuster-Meiseles, T., Beck, A., Petrovich, K., Gurevitch, D., Ronen, D., & Zick, Y. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0072 · Cited by 11 · cited 4×
“Potentially then, the disruptive effect of S307 phosphorylation might be an assay- or condition-dependent aspect of a more generalised S/T phosphorylation-based mechanism governing IRS signalling [5, 45, 46].”
BackgroundInfluentialFischman (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000262 · Cited by 6 · cited 1×
“Compatible with regulated ubiquitin/proteasomal processing of IRS1, exposure of HEK293 cells to very high insulin showed that about 50% of total IRS1 could be degraded within 10 min via internal cleavage around hS475 or hS641; however, the necessary factors were not investigated [67].”
BackgroundIκB kinase β (IKKβ) does not mediate feedback inhibition of the insulin signalling cascade
Lancaster, G. I., Skiba, B., Yang, C., Nicholls, H. T., Langley, K. G., Chan, S. M. H., Bruce, C. R., Rewcastle, G. W., Shepherd, P. R., Karin, M., et al. (2011) · Biochemical Journal · doi:10.1042/bj20112037 · Cited by 5 · cited 2×
“IRS1 tyrosine phosphorylation/PI3K activity or glucose uptake [169].”
BackgroundThe Mechanisms of Insulin Action
White, M. F., Copps, K. D., Özcan, U., & Tseng, Y. D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00034-4 · Cited by 3
Self-citation
Flagged first, then by citations
2 of the 185 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
Diabetes mellitus: The epidemic of the century
Kharroubi, A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.850 · Cited by 1,352
Insulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258
Insulin resistance: review of the underlying molecular mechanisms
Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929
“This process creates a suitable binding site for IRS‐1 that is then activated via phosphorylation by different insulin‐induced kinases such as PKC, SIK2, AKT, S6K1, mTOR, extracellular signal‐regulated kinase 1/2 (ERK1/2), and ROCK1 (Copps & White, 2012; Kiselyov et al., 2009).”
Background
Metadata
- Authors
- Copps, K. D., & White, M. F.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- White, M. F.
- ORCID
- White, M. F.
- Venue
- Diabetologia
- Published
- 2012-08-08
- Volume
- 55
- Issue
- 10
- Pages
- 2565-2582
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC4011499
- OpenAlex
- W1982479748
- Cited by
- 1,017
- References
- 185
- Citations by year
- 2026: 72 · 2025: 56 · 2024: 76 · 2023: 83 · 2022: 103 · 2021: 113 · 2020: 83 · 2019: 76 · 2018: 75 · 2017: 70 · 2016: 59 · 2015: 63 · 2014: 51 · 2013: 31 · 2012: 5
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5r01dk098655-08)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01- DK098655, R01DK038712)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin receptor substrate, IRS-1, insulin receptor substrate 2, serine/threonine phosphorylation, insulin sensitivity, insulin resistance, diabetes mellitus, insulin signaling, AMPK, glycogen synthase kinase-3, protein kinase C, Akt, mTOR, hyperinsulinemia, metabolic disorders
- MeSH terms
- Animals, Diabetes Mellitus, Humans, Insulin Resistance, Mice, Transgenic, Phosphorylation, Serine, Threonine, Signal Transduction, Mice, Knockout, Models, Animal, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review